83
Views
15
CrossRef citations to date
0
Altmetric
Review

Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens

Pages 139-148 | Published online: 26 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rachael Cusack, Alexis Garduno, Khalid Elkholy & Ignacio Martín-Loeches. (2022) Novel investigational treatments for ventilator-associated pneumonia and critically ill patients in the intensive care unit. Expert Opinion on Investigational Drugs 31:2, pages 173-192.
Read now
Vicenç Falcó, Joaquin Burgos, Elisabeth Papiol, Ricard Ferrer & Benito Almirante. (2016) Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia. Expert Opinion on Investigational Drugs 25:6, pages 653-665.
Read now
Sergio Ramírez-Estrada, Bárbara Borgatta & Jordi Rello. (2016) Pseudomonas aeruginosa ventilator-associated pneumonia management. Infection and Drug Resistance 9, pages 7-18.
Read now

Articles from other publishers (12)

Meng Wang, Lei Wang, Sana Shabbir, Dongliang Zhou, Muhammad Akbar Shahid, Houqiang Luo, Huixia Li, Ziwei Li, Xingya Sun, Chunqin Wu & Yan Zhao. (2023) Effects of thiram exposure on liver metabolism of chickens. Frontiers in Veterinary Science 10.
Crossref
Nao Yamamoto, Tatsuaki Tagami, Koki Ogawa & Tetsuya Ozeki. (2023) Arbekacin-Loaded Inhalable Nanocomposite Particles Specific to <i>Pseudomonas aeruginosa</i> Prepared Using a Two-Solution Mixing-Type Spray Nozzle. Biological and Pharmaceutical Bulletin 46:2, pages 201-208.
Crossref
Daniel Reynolds, Jason P. Burnham, Cristina Vazquez Guillamet, Mikaela McCabe, Valerie Yuenger, Kevin Betthauser, Scott T. Micek & Marin H. Kollef. (2022) The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic. European Respiratory Review 31:166, pages 220068.
Crossref
Harshad Lade, Hwang-Soo Joo & Jae-Seok Kim. (2022) Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus. Antibiotics 11:10, pages 1378.
Crossref
Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref
Harshad Lade & Jae-Seok Kim. (2021) Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus. Antibiotics 10:4, pages 398.
Crossref
Sujata M. Bhavnani, Jeffrey P. Hammel, Elizabeth A. Lakota, M. Courtney Safir, Brian D. VanScoy, Yu Nagira, Christopher M. Rubino, Nobuo Sato, Tomokazu Koresawa, Kenichiro Kondo & Paul G. Ambrose. (2020) Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution. Antimicrobial Agents and Chemotherapy 64:10.
Crossref
Despoina Koulenti, Elena Xu, Andrew Song, Isaac Yin Sum Mok, Drosos E. Karageorgopoulos, Apostolos Armaganidis, Sotirios Tsiodras & Jeffrey Lipman. (2020) Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms 8:2, pages 191.
Crossref
Elizabeth A. Lakota, Nobuo Sato, Tomokazu Koresawa, Kenichiro Kondo, Sujata M. Bhavnani, Paul G. Ambrose & Christopher M. Rubino. (2019) Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution. Antimicrobial Agents and Chemotherapy 63:8.
Crossref
Alisa W. Serio, Tiffany Keepers, Logan Andrews & Kevin M. Krause. (2018) Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. EcoSal Plus 8:1.
Crossref
Selina Y. L. Holbrook & Sylvie Garneau-Tsodikova. (2016) Expanding Aminoglycoside Resistance Enzyme Regiospecificity by Mutation and Truncation. Biochemistry 55:40, pages 5726-5737.
Crossref
Masaaki Minami, Ryoko Sakakibara, Taichi Imura, Hideo Morita, Naoto Kanemaki & Michio Ohta. (2015) Clinical Characteristics of Invasive Methicillin-Resistant Staphylococcus aureus at General Hospital in the Central Region of Japan from July 2014 to June 2015. Journal of Biosciences and Medicines 03:09, pages 9-14.
Crossref